Cargando…

Update on Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) in SARS-CoV-2 Infection

The SARS-CoV-2 outbreak is characterized by the need of the search for curative drugs for treatment. In this paper, we present an update of knowledge about the interest of the functional inhibitors of acid sphingomyelinase (FIASMAs) in SARS-CoV-2 infection. Forty-nine FIASMAs have been suggested in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loas, Gwenolé, Le Corre, Pascal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308787/ https://www.ncbi.nlm.nih.gov/pubmed/34358117 http://dx.doi.org/10.3390/ph14070691

Ejemplares similares

Association between Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) and Reduced Risk of Death in COVID-19 Patients: A Retrospective Cohort Study
por: Darquennes, Gil, et al.
Publicado: (2021)

Difficulty in Repurposing Selective Serotonin Reuptake Inhibitors and Other Antidepressants with Functional Inhibition of Acid Sphingomyelinase in COVID-19 Infection
por: Le Corre, Pascal, et al.
Publicado: (2022)

Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine
por: Schloer, Sebastian, et al.
Publicado: (2020)

Repurposing FIASMAs against Acid Sphingomyelinase for COVID-19: A Computational Molecular Docking and Dynamic Simulation Approach
por: Naz, Aliza, et al.
Publicado: (2023)

Association of Amlodipine with the Risk of In-Hospital Death in Patients with COVID-19 and Hypertension: A Reanalysis on 184 COVID-19 Patients with Hypertension
por: Loas, Gwenolé, et al.
Publicado: (2022)

Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19
por: Hoertel, Nicolas, et al.
Publicado: (2022)

Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19
por: Hoertel, N., et al.
Publicado: (2023)

Acid sphingomyelinase-mediated blood-brain barrier disruption in aging
por: Park, Min Hee, et al.
Publicado: (2019)

Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection
por: Gambichler, Thilo, et al.
Publicado: (2020)

Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells
por: Carpinteiro, Alexander, et al.
Publicado: (2020)

Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells
por: Carpinteiro, Alexander, et al.
Publicado: (2021)

Superantigens and SARS-CoV-2
por: Hamdy, Adam, et al.
Publicado: (2022)

SARS-CoV-2 infection induces the activation of tissue factor–mediated coagulation via activation of acid sphingomyelinase
por: Wang, Jue, et al.
Publicado: (2021)

Innate Immune Response in SARS-CoV-2 Infection
por: Schiuma, Giovanna, et al.
Publicado: (2022)

The Recombination Potential between SARS-CoV-2 and MERS-CoV from Cross-Species Spill-over Infections
por: Sajini, Abdulrahim A., et al.
Publicado: (2021)

Role of the early secretory pathway in SARS-CoV-2 infection
por: Sicari, Daria, et al.
Publicado: (2020)

SARS-CoV-2 infection and the antiviral innate immune response
por: Yang, Hui, et al.
Publicado: (2020)

Realization of humoral immunity against SARS-CoV-2 infections
por: Lin, Yong, et al.
Publicado: (2021)

SARS-CoV-2 infections in children: Understanding diverse outcomes
por: Brodin, Petter
Publicado: (2022)

Improving Nasal Protection for Preventing SARS-CoV-2 Infection
por: Nocini, Riccardo, et al.
Publicado: (2022)

Regulation of Neutral Amino Acid Transport By the SARS-CoV-2 Receptor ACE2
por: Loo, Donald D F, et al.
Publicado: (2021)

Equitable distribution of SARS-CoV-2 tests
por: Garcia-Bereguiain, Miguel Angel, et al.
Publicado: (2022)

SARS-CoV-2 and Arthropods: A Review
por: Higgs, Stephen, et al.
Publicado: (2022)

SARS-CoV-2 S Glycoprotein Stabilization Strategies
por: Pedenko, Borys, et al.
Publicado: (2023)

Higher binding affinity of furin for SARS-CoV-2 spike (S) protein D614G mutant could be associated with higher SARS-CoV-2 infectivity
por: Mohammad, Anwar, et al.
Publicado: (2021)

SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics
por: Cao, Qing, et al.
Publicado: (2020)

Mechanisms of infection by SARS-CoV-2, inflammation and potential links with the microbiome
por: Aguirre García, María Magdalena, et al.
Publicado: (2021)

Potential intestinal infection and faecal–oral transmission of SARS-CoV-2
por: Guo, Meng, et al.
Publicado: (2021)

Postacute sequelae of SARS-CoV-2 infection. Osteonecrosis must not be overlooked
por: Koutalos, Antonios A., et al.
Publicado: (2022)

Approaches and Challenges in SARS-CoV-2 Vaccine Development
por: Dagotto, Gabriel, et al.
Publicado: (2020)

Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity
por: Burtscher, Johannes, et al.
Publicado: (2020)

SARS-CoV-2 Vaccines in Patients With Multiple Myeloma
por: Gavriatopoulou, Maria, et al.
Publicado: (2021)

Environmental factors and their role in the transmission of SARS-CoV-2
por: Maciorowski, Dawid, et al.
Publicado: (2021)

Adapting Serosurveys for the SARS-CoV-2 Vaccine Era
por: Duarte, Nathan, et al.
Publicado: (2021)

SARS‐CoV‐2 Omicron variant: Characteristics and prevention
por: He, Xuemei, et al.
Publicado: (2021)

SARS-CoV-2 and probable lung cancer risk
por: Khiali, Sajad, et al.
Publicado: (2022)

What SARS-CoV-2 does to our brains
por: Aschman, Tom, et al.
Publicado: (2022)

Back to Science in Searching for SARS-CoV-2 Origins
por: Liu, William J, et al.
Publicado: (2023)

SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
por: Lipsitch, Marc, et al.
Publicado: (2021)

The Possible Role of Glucose-6-Phosphate Dehydrogenase in the SARS-CoV-2 Infection
por: Pérez-Torres, Israel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cr9eldvrlutq3jns0doff1pioi